To read the full reviews, click on the links for each section.
– Introduction
https://www.meresearch.org.uk/2024-25-our-charity-year-in-review-introduction/
“ME Research UK’s vision is to end the suffering caused by ME/CFS by investing in high quality, scientific (biomedical) research into the causes, consequences and treatment(s) of the illness. Only through biomedical research will the disease be understood, accepted, and real change to the lived experience of those with the illness become a reality.”
– Informing
https://www.meresearch.org.uk/2024-25-our-charity-year-in-review-informing/
“During 2024/25, the charity continued its role as an independent, science-centred provider of high-quality information and education for key decision-makers, healthcare professionals and those affected directly or indirectly by ME/CFS.”
– Influencing
https://www.meresearch.org.uk/2024-25-our-charity-year-in-review-influencing/
“ME Research UK supporting calls for creation of internationally recognised and operationalised research criteria for ME. In doing so, it joined leading researchers, clinicians, fellow charities, patients, advocates, and supporters from across the globe.”
– Investing
https://www.meresearch.org.uk/2024-25-our-charity-year-in-review-investing/
“During the charity year to 31st October 2025 the charity has invested a further £866,328.80 into ME research covering 6 ME/CFS research projects in 4 countries (Australia, Latvia, Belgium and UK) plus a Fellowship, and including an offer to fund a further UK project which was made before 31st October 2025.”
